The Rapid Development of Fluoroquinolone Resistance in M. tuberculosis [7]

New England Journal of Medicine

Volumn 349, Issue 20, 2003, Pages 1977-1978

  Ginsburg, Amy Sarah ^a   Woolwine, Samuel C ^a   Hooper, Nancy ^b   Benjamin Jr , William H ^c   Bishai, William R ^a   Dorman, Susan E ^a   Sterling, Timothy R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Maryland State Department of Health and Mental Hygiene   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CASE REPORT; GENE AMPLIFICATION; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; MISSENSE MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSURETHRAL RESECTION; URINE CULTURE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; PROSTATITIS; TUBERCULOSIS;

EID: 0242574666     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200311133492023     Document Type: Letter

References (5)

1. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes: tentative standard. 2nd ed. Document M24-T2. Vol. 20. Wayne, Pa.: NCCLS, 2000:1-58.
2. van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31: 406-9.
3. Perlman DC, El Sadr WM, Heifets LB, et al. Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. AIDS 1997;11:1473-8.
4. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens. MMWR Morb Mortal Wkly Rep 2002;51: 214-5.
5. Takiff HE, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994;38:773-80.